| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/08/2004 | WO2003020876A3 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 01/08/2004 | WO2003016505A3 Kgf polypeptide compositions |
| 01/08/2004 | WO2003013598A3 Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases |
| 01/08/2004 | WO2003012057A3 Antisense modulation of serum amyloid a4 expression |
| 01/08/2004 | WO2003008610A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced pfkb gene |
| 01/08/2004 | WO2003008609A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced pykf gene |
| 01/08/2004 | WO2003007890A3 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor |
| 01/08/2004 | WO2003007800A3 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/08/2004 | WO2003004658A3 Gene expression in plastids based on replicating vectors |
| 01/08/2004 | WO2003003018A3 Method for identifying compounds for the therapy of aging of the cardiovascular system |
| 01/08/2004 | WO2003000859A3 G-protein coupled receptors |
| 01/08/2004 | WO2002103016B1 Human tachykinin-related splice variants and compositions thereof |
| 01/08/2004 | WO2002099036A3 Inhibition of neurodegeneration |
| 01/08/2004 | WO2002095067A3 INTERFERON α-14 POLYMORPHISM |
| 01/08/2004 | WO2002092623A8 INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF |
| 01/08/2004 | WO2002091996A3 Methods for treating cancer |
| 01/08/2004 | WO2002088313A3 Novel human nuclear transporters and polynucleotides encoding the same |
| 01/08/2004 | WO2002080952A3 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |
| 01/08/2004 | WO2002068650B1 Modified and stabilized gdf propeptides and uses thereof |
| 01/08/2004 | WO2002066622A3 Method of generating diversity into lipolytic enzymes and lipolytic enzyme genes |
| 01/08/2004 | WO2002064797A3 Mitochondrial topoisomerase i |
| 01/08/2004 | WO2002064782A3 Rank ligand-binding polypeptides |
| 01/08/2004 | WO2002059310A3 Polynucleotides encoding cellular transporters and methods of use thereof |
| 01/08/2004 | WO2002055697A3 Human rhinovirus assays, and compositions comprising anti-rhinoviral perturbagens |
| 01/08/2004 | WO2002053596A3 Antibodies to insulin-like growth factor i receptor |
| 01/08/2004 | WO2002051989A3 Human 4-nitrophenylphosphatase |
| 01/08/2004 | WO2002046458A3 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 01/08/2004 | WO2002046225A3 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 01/08/2004 | WO2002046217A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/08/2004 | WO2002045737A3 Methods of treatment involving human mda-7 |
| 01/08/2004 | WO2002044373A3 Adipocyte complement related protein zacrp12 |
| 01/08/2004 | WO2002038761A3 Regulation of human oat-like protein |
| 01/08/2004 | WO2002038613A3 Modified recombinase |
| 01/08/2004 | WO2002036782A3 Novel glyphosate n-acetyltransferase (gat) genes |
| 01/08/2004 | WO2002034776A3 Epitopes of pai-1 |
| 01/08/2004 | WO2002008265A3 Staphylococcus aureus ribosomal protein s20, corresponding gene and methods for the identification of antibacterial substances |
| 01/08/2004 | WO2002006345A3 G-protein coupled receptor proteins (gpcr) and nucleic acids encoding same |
| 01/08/2004 | WO2001079524A3 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof |
| 01/08/2004 | WO2000052135A3 Engineering intracellular sialylation pathways |
| 01/08/2004 | US20040006797 Comprises expression vector coding root hair regulatory protein for generating and propagating plants and seeds with improved yields, drought tolerance and/or elevated seed oil concentrations |
| 01/08/2004 | US20040006796 Methods of modulating cytokinin related processes in a plant using B3 domain proteins |
| 01/08/2004 | US20040006795 Increasing flavonoid production in soy bean plants; food processing; nutrients; beverages |
| 01/08/2004 | US20040006794 Bioengineering cotton fiber properties |
| 01/08/2004 | US20040006793 Novel regulatory genes involved in condensed tannin synthesis in plants |
| 01/08/2004 | US20040006792 Soybean seeds exhibiting oil composition which comprises varying concentrations of oleic acid, linoleic acid, linolenic acid and saturated fatty acids; vegetable oils |
| 01/08/2004 | US20040006791 Endoglucanase gene promoter upregulated by the root-knot nematode |
| 01/08/2004 | US20040006790 Generating disease resistant cucumbers; biological pest control; fungicides |
| 01/08/2004 | US20040006789 Pseudomonas syringae harpins, HopPtoP and HopPmaHpto, and their uses |
| 01/08/2004 | US20040006788 Procedures and materials for conferring disease resistance in plants |
| 01/08/2004 | US20040006787 Propagation of genetically engineered tomato coding avirulent kinase (AVR-pto) which imparts resistance to bacterial speck disease; agriculture; bioloical pest control |
| 01/08/2004 | US20040006786 Novel glycine-rich gene |
| 01/08/2004 | US20040006785 For controlling flea beetles of the genus Phyllotreta |
| 01/08/2004 | US20040006784 Methods and compositions for producing plants and microorganisms that express feedback insensitive threonine dehydratase/deaminase |
| 01/08/2004 | US20040006783 Comprises nucleotide sequences coding a guanosine triphosphatase with a cyclin dependent kinase rac-interactive binding (CRIB) motif for generating transgenic plants with improved growth in decreased oxygen |
| 01/08/2004 | US20040006782 Non-human mammal mutant for expression of the alpha6 subunit of the nicotinic acetylcholine receptor, and use for screening substances that can interact with said receptor |
| 01/08/2004 | US20040006780 VEGF-modulated genes and methods employing them |
| 01/08/2004 | US20040006779 Antibodies against gene products related to werner's syndrome |
| 01/08/2004 | US20040006776 Transgenic production of antibodies in milk |
| 01/08/2004 | US20040006775 Invention provides mice having reduced constitutive androstane receptor activity and mice expressing a human CAR receptor |
| 01/08/2004 | US20040006220 Antisense modulation of insulin-like growth factor 2 expression |
| 01/08/2004 | US20040006217 Comprises coagulation factor VIIa/VII receptor for treatment and prevention of thrombosis, septic shock and adult respiratory distress syndrome (ARDS); anticoagulants; thrombolytic agents |
| 01/08/2004 | US20040006216 Comprises immunoglobulin for treating cancer; immunosuppressant; immunotherapy |
| 01/08/2004 | US20040006215 Human monoclonal antibodies against CD30 |
| 01/08/2004 | US20040006213 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use |
| 01/08/2004 | US20040006211 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006209 Comprises immunoglobulin which specifically binds staphylococcal g-protein and receptor sites for preventing and treating infections; gentic vaccines |
| 01/08/2004 | US20040006207 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 01/08/2004 | US20040006205 Comprises g-protein coupled receptor polypeptides for diagnosis, prevention and treatment of cancers, infections and dyslipidemias |
| 01/08/2004 | US20040006129 Administering compound selected from 4,4'-(isopropylidenedithio) bis(2,6-di-tert-butylphenol), 2,3-Dihydro-5-hydroxy-2 2-dipentyl-4,6-di-tert-butyl-benzofuran, vitamin E and vitamin c |
| 01/08/2004 | US20040006039 Neutral sphingomyelinase antisense ribozyme and uses thereof |
| 01/08/2004 | US20040006038 Method for therapy of rheumatoid arthritis |
| 01/08/2004 | US20040006036 Silencing transcription by methylation |
| 01/08/2004 | US20040006035 For modulating HIV cell fusion activity in a cell |
| 01/08/2004 | US20040006032 Vaccination |
| 01/08/2004 | US20040006031 For therapy of disease or condition such as cholesterol metabolism, cardiovascular disease, atherosclerosis, angiogenesis |
| 01/08/2004 | US20040006030 For therapy of hyperproliferative disorder, hyperactivation of an immune response, neurodegenerative disorder |
| 01/08/2004 | US20040006029 Antisense modulation of cell division cycle 2 expression |
| 01/08/2004 | US20040006026 For use as antibiotics, in therapy of infectious diseases |
| 01/08/2004 | US20040006010 Compositions include a polynucleotide that is linked to an immunomodulatory molecule, which molecule comprises an antigen and may further comprise immunomodulators such as cytokines and adjuvants. The polynucleotide portion of the |
| 01/08/2004 | US20040006008 Localize to a specific subcellular compartment such as the lysosome are provided. The targeted therapeutics include a therapeutic agent and a targeting moiety that binds a receptor on an exterior surface of the cell, permitting proper |
| 01/08/2004 | US20040006006 Polypeptide (CD40-L) and DNA sequences, vectors and transformed host cells useful in providing CD40-L polypeptides. More particularly, this invention provides isolated human and murine CD40-L polypeptides that bind to the |
| 01/08/2004 | US20040006005 Treating conditions of insulin resistance, hyperglycemia and/or diabetes. In a broad embodiment, the methods comprise the step of administering to a mammal in need of treatment a therapeutically effective amount of an ILK inhibitor. |
| 01/08/2004 | US20040006004 This invention concerns a method for treating or preventing a disease or disorder related to excessive formation of vascular tissue or blood vessels in a patient, said method comprising administering to said patient an agent affecting the NPY Y2 |
| 01/08/2004 | US20040006001 Ferritin fusion proteins for use in vaccines and other applications |
| 01/08/2004 | US20040005718 Method of fixing biopolymers to a substrate using magnetic beads and biopolymer measuring equipment using the method |
| 01/08/2004 | US20040005713 Mobilization of viral genomes from T-DNA using site-specific recombination systems |
| 01/08/2004 | US20040005711 Alphaviral vector system comprising papilloma viral orgin of replication and antitumor agent for prevention and treatment urogenital cancer; gene therapy |
| 01/08/2004 | US20040005710 Method for producing recombinant viruses using site-specific recombination |
| 01/08/2004 | US20040005709 Hybridization control of sequence variation |
| 01/08/2004 | US20040005708 For gene therapy, transferring therapeutic genes into cells |
| 01/08/2004 | US20040005707 Antisense modulation of integrin beta 5 expression |
| 01/08/2004 | US20040005706 Antisense modulation of DEXRAS1 expression |
| 01/08/2004 | US20040005705 Comprises oligonucleotides for controlling expression of phospholipase D2 and treating cancer and nervous system disorders; gene expression inhibition; antisense therapy |
| 01/08/2004 | US20040005704 Propagating neuronal cells in reduced oxygen environment for treating parkinson's and neurodegenerative diseases; in vitro culture and cell differentiation/proliferation; gene therapy; tissue engineering; antiapoptosis |
| 01/08/2004 | US20040005702 Immortalized human pancreatic cell line produced by electrofusion and which secretes insulin for treating diabetes; gene therapy; tissue engineering |
| 01/08/2004 | US20040005700 Poroplasts |
| 01/08/2004 | US20040005697 Apparatus comprised of hydrophilic surface and coupling matrix for detecting and analyzing nucleic acids, proteins, macromolecules and other haptens |
| 01/08/2004 | US20040005695 Culturing genetically engineered escherichia and/or klebsiella coding phytase and/or amylase and recovering enzymatic polypeptides |
| 01/08/2004 | US20040005692 Comprises nucleotide sequences coding amidase (AMDS) for use as diagnostic tool in genetic engineering |